Dexcom, Inc., headquartered in San Diego, CA, provides continuous glucose monitoring (CGM) products for adult and pediatric patients as young as two years old. The Dexcom G5® Mobile CGM System is the first CGM system FDA-approved for use in making treatment diabetes decisions* and the only one covered by Medicare.

*Fingersticks required for calibration, or if symptoms or expectations do not match readings, or when taking medications containing acetaminophen.

Booth Number: 
Exhibitor Type: 
Other Specific Disease State Products/Services